Role of Renal Sympathetic Nerves in GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist Exendin-4-Mediated Diuresis and Natriuresis in Diet-Induced Obese Rats

被引:9
作者
Liu, Xuefei [1 ]
Patel, Kaushik P. [2 ]
Zheng, Hong [1 ]
机构
[1] Univ South Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA
[2] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 21期
基金
美国国家卫生研究院;
关键词
glucagon-like peptide-1; neprilysin; obesity; renal nerve; sodium retention; BLOOD-PRESSURE; HEART-FAILURE; SODIUM-EXCRETION; HYPERTENSION; NEPRILYSIN; LIRAGLUTIDE; EXPRESSION; IMPACT; INJURY;
D O I
10.1161/JAHA.121.022542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The gut-derived hormone GLP-1 (glucagon-like peptide-1) exerts beneficial effects against established risk factors for chronic kidney disease. GLP-1 influences renal function by stimulating diuresis and natriuresis and thus lowering arterial blood pressure. The role of the sympathetic nervous system has been implicated as an important link between obesity with elevated arterial pressure and chronic kidney disease. The primary aim of this study was to determine the contribution of renal sympathetic nerves on intrapelvic GLP-1-mediated diuresis and natriuresis in high-fat diet (HFD)-induced obese rats. Methods and Results Obesity was induced in rats by HFD for 12 weeks, followed by either surgical bilateral renal denervation or chronic subcutaneous endopeptidase neprilysin inhibition by sacubitril for a week. Diuretic and natriuretic responses to intrapelvic administration of the GLP-1R (GLP-1 receptor) agonist exendin-4 were monitored in anesthetized control and HFD rats. Renal GLP-1R expression and neprilysin expression and activity were measured. The effects of norepinephrine on the expression of GLP-1R and neprilysin in kidney epithelial LLC-PK1 cells were also examined. We found that diuretic and natriuretic responses to exendin-4 were significantly reduced in the HFD obese rats compared with the control rats (cumulative urine flow at 40 minutes, 387 +/- 32 versus 650 +/- 65 mu L/gkw; cumulative sodium excretion at 40 minutes, 42 +/- 5 versus 75 +/- 10 mu Eq/gkw, P<0.05). These responses in the HFD rats were restored after ablation of renal nerves (cumulative urine flow at 40 minutes, 625 +/- 62 versus 387 +/- 32 mu L/gkw; cumulative sodium excretion at 40 minutes, 70 +/- 9 versus 42 +/- 5 mu Eq/gkw, P<0.05). Renal denervation induced significant reductions in arterial pressure and heart rate responses to intrapelvic GLP-1 in the HFD rats. Renal denervation also significantly increased the GLP-1R expression and reduced neprilysin expression and activity in renal tissues from the HFD rats. Chronic subcutaneous neprilysin inhibition by sacubitril increased GLP-1-induced diuretic and natriuretic effects in the HFD rats. Finally, exposure of the renal epithelial cells to norepinephrine in vitro led to downregulation of GLP-1R expression but upregulation of neprilysin expression and activity. Conclusions These results suggest that renal sympathetic nerve activation contributes to the blunted diuretic and natriuretic effects of GLP-1 in HFD obese rats. This study provides significant novel insight into the potential renal nerve-neprilysin-GLP-1 pathway involved in renal dysfunction during obesity that leads to hypertension.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review
    West, Juliana
    Li, Maggie
    Wong, Sabrina
    Le, Gia Han
    Teopiz, Kayla M.
    Valentino, Kyle
    Dri, Christine E.
    McIntyre, Roger S.
    NEUROLOGY AND THERAPY, 2025,
  • [42] GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
    Nahmias, Avital
    Stahel, Priska
    Tian, Lili
    Xiao, Changting
    Lewis, Gary F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (06) : 1893 - 1900
  • [43] Dipeptidyl peptidase-4 (DPP-4) inhibitors are favourable to Glucagon-Like Peptide-1 (GLP-1) agonists: No
    Madsbad, Sten
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (02) : 132 - 136
  • [44] The Effect of Feeding Behavior on Hypothalamus in Obese Type 2 Diabetic Rats with Glucagon-like Peptide-1 Receptor Agonist Intervention
    Lu, Ke
    Chen, Xiaoyan
    Yan, Jianhua
    Li, Xinchun
    Huang, Chen
    Wan, Qi
    Deng, Xuelian
    Zou, Qiao
    OBESITY FACTS, 2018, 11 (03) : 181 - 194
  • [45] Systematic Design of Trypsin Cleavage Site Mutated Exendin4-Cysteine 1, an Orally Bioavailable Glucagon-Like Peptide-1 Receptor Agonist
    Sai, Wenbo
    Tian, Hong
    Yang, Kangmin
    Tang, Daoqi
    Bao, Jinxiao
    Ge, Yang
    Song, Xiaoda
    Zhang, Yu
    Luo, Cheng
    Gao, Xiangdong
    Yao, Wenbing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03)
  • [46] Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice
    Kissow, Hannelouise
    Hartmann, Bolette
    Holst, Jens Juul
    Viby, Niels-Erik
    Hansen, Laerke Schmidt
    Rosenkilde, Mette Marie
    Hare, Kristine Juul
    Poulsen, Steen Seier
    REGULATORY PEPTIDES, 2012, 179 (1-3) : 91 - 100
  • [47] Renal Function Improvement With Glucagon-Like Peptide-1 Receptor Agonist in a Patient With Type 2 Diabetes
    Yanai, Hidekatsu
    JOURNAL OF MEDICAL CASES, 2024, 15 (2-3) : 37 - 42
  • [48] Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
    Nguyen, Hiep
    Dufour, Robert
    Caldwell-Tarr, Amanda
    ADVANCES IN THERAPY, 2017, 34 (03) : 658 - 673
  • [49] Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
    Ma, Xue
    Meng, Jingru
    Jia, Min
    Bi, Long
    Zhou, Ying
    Wang, Yukun
    Hu, Jing
    He, Gonghao
    Luo, Xiaoxing
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (07) : 1641 - 1652
  • [50] Glucagon-Like Peptide-1 Receptor Agonist Administration Suppresses Both Water and Saline Intake in Rats
    McKay, N. J.
    Daniels, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2013, 25 (10) : 929 - 938